• Spearheaded the development of clinical biomarker discovery strategies in biofluids (blood, urine) for informed decision making and drug development in immuno-oncology (including FDA/EMA-approved anti-PD-1/PD-L1 antibodies and novel antibody-drug conjugates), by analysing multi-omics dataset which allowed to develop AI-based precision medicine tools.• Employed a variety of creative bioinformatic approaches, primarily R-based, for optimal multi-omics data analysis (DNA-seq, RNA-seq, proteomics) and visualization in conjunction with clinical metadata.• Worked closely with a law office for the preparation of intellectual-propriety documentation and patent filling of clinical biomarker applications.• Managed grant preparation with renown academic and industrial partners by ensuring task distribution and completion, CRO engagement and meeting the deadlines, which led to multiple applications and to secure an InnoSuisse grant worth 400’000 CHF.• Actively engaged in scientific communication by leading poster, brochure, and peer-reviewed article preparation, effectively disseminating research findings to a broader audience, including a successful business pitch which received the “2024 best technology award” by the MATWIN international board.• Involved in conversations with the senior management, as well as in the mentoring of a Master student, to provide valuable scientific input in the context of company objectives.

• In collaboration with renowned pharmaceutical companies, investigated the efficacy of therapeutic antibodies and bispecific antibodies (targeting CSF1R and VEGF-A/ANG2, respectively) to target the microenvironment of neurological tumors in animal models, which enabled go/no-go decisions for the subsequent clinical application. • Development and computational analysis of translational multi-imaging methods (magnetic resonance imaging, 2-photon microscopy and multi-plex immunofluorescence) for neurological applications.• Assessed the pharmacokinetics-pharmacodynamics of brain-targeted anti-CSF1R therapeutic antibody enabling an understanding of its mechanism of action, and to optimize pre-clinical trials, including dose review. • Proficient data presentation in renowned international scientific conferences and high impact factor journals, as well as in public meetings rising interest for my projects.

• Successfully managed the customer discovery process through LinkedIn search, reporting to the direct supervisor and enabled the company to contact potential clients.

• Actively involved in managing a novel drug development project and successfully established a new cellular assay for the screening of small-molecules.• Coordinated projects between multi-disciplinary teams with regular meetings and effective presentations of data, which led to the task optimisation and better team efficiency.

• Part of the civil service. Involved in several projects on protein biology.